Hypoglycemia Induces Diabetic Macrovascular Endothelial Dysfunction via Endothelial Cell PANoptosis, Macrophage Polarization, and VSMC Fibrosis
Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia‐triggered cytokine release and inflammatory programmed cell de...
Uložené v:
| Vydané v: | Advanced science Ročník 12; číslo 37; s. e14530 - n/a |
|---|---|
| Hlavní autori: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Germany
John Wiley & Sons, Inc
01.10.2025
Wiley |
| Predmet: | |
| ISSN: | 2198-3844, 2198-3844 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia‐triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage‐specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single‐nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin‐induced hypoglycemic db/db mice. Comparative analyses show changes in lineage‐specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo‐time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment.
This study investigates hypoglycemia‐induced diabetic macrovascular endothelial dysfunction. It reveals that hypoglycemia triggers ZBP1‐dependent PANoptosis of endothelial cells, proinflammatory polarization of macrophages, and fibrosis of vascular smooth muscle cells (VSMCs) in diabetic mice. Key regulators are identified, with ANGPTL4 validated as a pro‐fibrotic activator. The findings elucidate cellular mechanisms and offer therapeutic insights for hypoglycemia‐related cardiovascular events. |
|---|---|
| AbstractList | Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia‐triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage‐specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single‐nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin‐induced hypoglycemic db/db mice. Comparative analyses show changes in lineage‐specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo‐time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment.
This study investigates hypoglycemia‐induced diabetic macrovascular endothelial dysfunction. It reveals that hypoglycemia triggers ZBP1‐dependent PANoptosis of endothelial cells, proinflammatory polarization of macrophages, and fibrosis of vascular smooth muscle cells (VSMCs) in diabetic mice. Key regulators are identified, with ANGPTL4 validated as a pro‐fibrotic activator. The findings elucidate cellular mechanisms and offer therapeutic insights for hypoglycemia‐related cardiovascular events. Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia‐triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage‐specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single‐nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin‐induced hypoglycemic db/db mice. Comparative analyses show changes in lineage‐specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo‐time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2 , ETS2 , Elavl1 , C3 , and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment. Abstract Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia‐triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage‐specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single‐nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin‐induced hypoglycemic db/db mice. Comparative analyses show changes in lineage‐specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo‐time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment. Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia-triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage-specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single-nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin-induced hypoglycemic db/db mice. Comparative analyses show changes in lineage-specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo-time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment.Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia-triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage-specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single-nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin-induced hypoglycemic db/db mice. Comparative analyses show changes in lineage-specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo-time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment. |
| Author | Cheng, Zhesheng Zuo, Deyu Chang, Shuting Lv, Dingyi Peng, Yuce Li, Na Luo, Minghao Li, Xunjia Huang, Yanyao Zhao, Guozhi He, An |
| Author_xml | – sequence: 1 givenname: Deyu surname: Zuo fullname: Zuo, Deyu organization: Chongqing Precision Medical Industry Technology Research Institute – sequence: 2 givenname: Yuce orcidid: 0000-0002-2095-8713 surname: Peng fullname: Peng, Yuce organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 3 givenname: Guozhi surname: Zhao fullname: Zhao, Guozhi organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 4 givenname: Zhesheng surname: Cheng fullname: Cheng, Zhesheng organization: St. John's University – sequence: 5 givenname: Minghao surname: Luo fullname: Luo, Minghao organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 6 givenname: Dingyi surname: Lv fullname: Lv, Dingyi organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 7 givenname: Shuting surname: Chang fullname: Chang, Shuting organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 8 givenname: Na surname: Li fullname: Li, Na organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 9 givenname: Yanyao surname: Huang fullname: Huang, Yanyao organization: Cardiovascular Disease Laboratory of Chongqing Medical University – sequence: 10 givenname: Xunjia surname: Li fullname: Li, Xunjia email: lixunjia@cqctcm.edu.cn organization: Chongqing Precision Medical Industry Technology Research Institute – sequence: 11 givenname: An surname: He fullname: He, An email: an.he@hospital.cqmu.edu.cn organization: Cardiovascular Disease Laboratory of Chongqing Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40650639$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstuEzEYhUeoiJbSLUtkiQ2LJvg2viyjpKWRWqhU6NbyeOzU0WQc7Jmg6Uv0lXGYElVsWNmyv3Pk__i8LY7a0NqieI_gFEGIP-t6l6YYYopoSeCr4gQjKSZEUHr0Yn9cnKW0hhCiknCKxJvimEJWQkbkSfF0NWzDqhmM3XgNlm3dG5vAwuvKdt6AG21i2Olk-kZHcNHWoXuwjdcNWAzJ9a3pfGjBLktf3s1t04Db2dew7ULy6Xy02T7olQW3ITv5R70XngPd1uD-7mYOLn0V9-y74rXTTbJnz-tp8ePy4vv8anL97ctyPrueGEowmrA8AHdCQIxNibClTjhKqWM1R447SCvjhIFcclcaxrE0uKKVZKXmiCGNyWmxHH3roNdqG_1Gx0EF7dWfgxBXSsecQGMVKStT1biqnRSUCSERh5TVmggpGbVV9vo0em1j-Nnb1KmNTyZnoFsb-qQIxpJhKSXN6Md_0HXoY5snzVTJCWWM8kx9eKb6amPrw_P-flsGpiOQY00pWndAEFT7aqh9NdShGllQjoJfvrHDf2g1W9zfccgxIr8BjwG7IQ |
| Cites_doi | 10.1161/CIRCULATIONAHA.122.063029 10.1186/s12864-018-4772-0 10.1016/S0140-6736(12)60110-X 10.1016/j.mvr.2022.104468 10.1016/j.vph.2022.106968 10.3389/fimmu.2022.988766 10.7554/eLife.67481 10.1007/s00125-017-4422-0 10.1038/s41467-020-14766-3 10.14336/AD.2023.0505 10.1038/gene.2011.21 10.1111/jcmm.15961 10.1016/j.molmed.2019.05.010 10.3389/fonc.2021.642144 10.1038/s41392-020-00303-7 10.1038/nri3818 10.1161/ATVBAHA.115.306672 10.1038/s41467-020-18957-w 10.1136/gutjnl-2021-326350 10.1016/j.cell.2020.12.008 10.1038/288373a0 10.1016/j.bbadis.2021.166170 10.1038/s41575-021-00543-0 10.1111/dom.12871 10.2337/dc09-0354 10.1038/nm.3777 10.3390/cells11091538 10.1038/s41467-020-15636-8 10.1038/s41421-022-00490-3 10.1016/j.metabol.2016.09.001 10.1038/s41419-022-05115-x 10.7150/ijbs.79915 10.1161/CIRCRESAHA.118.314402 10.1038/s41586-019-0979-8 10.3389/fimmu.2019.01312 10.1038/s41589-019-0462-8 10.3390/ijms23020792 10.3389/fimmu.2020.598877 10.1093/bioinformatics/bty332 10.1016/j.smim.2019.101296 10.3389/fimmu.2020.01276 10.1124/pharmrev.120.000096 10.1016/j.cell.2020.01.015 10.1111/imr.13147 10.1016/j.jbc.2021.101284 10.1111/imr.13279 10.1161/CIRCRESAHA.111.243444 10.1016/j.nano.2015.09.012 10.1016/j.immuni.2019.03.007 10.1155/2022/7812407 10.1038/s41598-023-43221-8 10.1146/annurev-publhealth-052620-091107 10.1016/j.cell.2022.04.004 10.1016/S0140-6736(23)01301-6 10.1007/s00441-023-03741-1 10.2337/db22-0246 10.1016/j.immuni.2023.08.002 10.1038/s44161-022-00138-1 |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH. 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH – notice: 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH. – notice: 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 88I 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH HCIFZ M2O M2P MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 DOA |
| DOI | 10.1002/advs.202414530 |
| DatabaseName | Wiley-Blackwell Open Access Titles CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea ProQuest Central Student Research Library Prep SciTech Premium Collection Research Library Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Science Journals (Alumni Edition) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 2198-3844 |
| EndPage | n/a |
| ExternalDocumentID | oai_doaj_org_article_35bcbd2bdf984688917046da389964eb 40650639 10_1002_advs_202414530 ADVS70721 |
| Genre | researchArticle Journal Article |
| GrantInformation_xml | – fundername: China Postdoctoral Science Foundation General Funding Program funderid: 2024MD754010 – fundername: National Natural Science Foundation of China funderid: 82305006; 82300477 – fundername: The Chongqing Medical Young Talents Program funderid: YXQN202415 – fundername: Chongqing Natural Science Foundation funderid: CSTB2024NSCQ‐MSX0320; CSTB2022NSCQ‐MSX0081 – fundername: Chongqing Postdoctoral Innovative Talent Support Program funderid: CQBX202213 – fundername: Chongqing Natural Science Foundation Innovation and Development Joint Fund funderid: CSTB2024NSCQ‐ LZX0079 – fundername: National Natural Science Foundation of China grantid: 82305006 – fundername: China Postdoctoral Science Foundation General Funding Program grantid: 2024MD754010 – fundername: National Natural Science Foundation of China grantid: 82300477 – fundername: The Chongqing Medical Young Talents Program grantid: YXQN202415 – fundername: Chongqing Natural Science Foundation Innovation and Development Joint Fund grantid: CSTB2024NSCQ- LZX0079 – fundername: Chongqing Natural Science Foundation grantid: CSTB2024NSCQ-MSX0320 – fundername: Chongqing Natural Science Foundation grantid: CSTB2022NSCQ-MSX0081 – fundername: Chongqing Postdoctoral Innovative Talent Support Program grantid: CQBX202213 |
| GroupedDBID | 0R~ 1OC 24P 53G 5VS 88I 8G5 AAFWJ AAMMB AAZKR ABDBF ABUWG ACCMX ACGFS ACUHS ACXQS ADBBV ADKYN ADMLS ADZMN AEFGJ AFBPY AFKRA AFPKN AGXDD AIDQK AIDYY ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU AZQEC BCNDV BENPR BPHCQ BRXPI CCPQU DWQXO EBS GNUQQ GODZA GROUPED_DOAJ GUQSH HCIFZ HYE IAO IGS ITC KQ8 M2O M2P O9- OK1 PHGZM PHGZT PIMPY PQQKQ PROAC ROL RPM WIN AAYXX AFFHD CITATION EJD CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c4321-60657f88022c512e4f8f444f6d71f7f04bcf8c0797f5c6729c2b4b965a7161a23 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001526665700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2198-3844 |
| IngestDate | Mon Oct 13 19:21:41 EDT 2025 Fri Sep 05 15:40:29 EDT 2025 Thu Nov 20 16:51:05 EST 2025 Thu Oct 09 01:30:57 EDT 2025 Thu Nov 27 00:54:27 EST 2025 Mon Oct 06 09:30:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 37 |
| Keywords | proinflammatory polarization fibrosis ANGPTL4 PANoptosis hypoglycemia |
| Language | English |
| License | Attribution 2025 The Author(s). Advanced Science published by Wiley‐VCH GmbH. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4321-60657f88022c512e4f8f444f6d71f7f04bcf8c0797f5c6729c2b4b965a7161a23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2095-8713 |
| OpenAccessLink | https://www.proquest.com/docview/3257346647?pq-origsite=%requestingapplication% |
| PMID | 40650639 |
| PQID | 3257346647 |
| PQPubID | 4365299 |
| PageCount | 21 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_35bcbd2bdf984688917046da389964eb proquest_miscellaneous_3229629994 proquest_journals_3257346647 pubmed_primary_40650639 crossref_primary_10_1002_advs_202414530 wiley_primary_10_1002_advs_202414530_ADVS70721 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-10-01 |
| PublicationDateYYYYMMDD | 2025-10-01 |
| PublicationDate_xml | – month: 10 year: 2025 text: 2025-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Weinheim |
| PublicationTitle | Advanced science |
| PublicationTitleAlternate | Adv Sci (Weinh) |
| PublicationYear | 2025 |
| Publisher | John Wiley & Sons, Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
| References | 2019; 50 2022; 71 2019; 10 2023; 146 2023; 9 2022; 23 2020; 16 2019; 567 2023; 148 2024; 187 2019; 125 2011; 12 2020; 11 2021; 73 2016; 36 2020; 5 2019; 25 2025; 28 2018; 34 2012; 379 2010; 5 2019; 7 2010; 33 2015; 15 2023; 13 2023; 14 2023; 56 2020; 180 2023; 19 2020; 183 2023; 402 2024; 321 2022; 43 2018; 61 2016; 12 2018; 19 2022; 143 2011; 109 2021; 10 2022; 185 2022; 2022 2021; 11 2019; 42 2022; 61 2021; 1867 2023; 392 2015; 21 2016; 65 2022; 12 2022; 13 2023; 313 2017; 19 2020; 24 2022; 1 2021; 297 2022; 11 1980; 288 2022; 19 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_18_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 Newton K. (e_1_2_10_11_1) 2024; 187 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_58_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_51_1 Zhang H. (e_1_2_10_30_1) 2021; 10 e_1_2_10_61_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_27_1 e_1_2_10_65_1 e_1_2_10_25_1 e_1_2_10_48_1 Amiel S. A. (e_1_2_10_4_1) 2019; 7 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_1_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_56_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 Zuo D. (e_1_2_10_31_1) 2022; 12 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 Hui T. (e_1_2_10_3_1) 2022; 61 e_1_2_10_50_1 Lecarpentier Y. (e_1_2_10_32_1) 2010; 5 e_1_2_10_60_1 e_1_2_10_62_1 Cui H. (e_1_2_10_52_1) 2025; 28 e_1_2_10_64_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_26_1 e_1_2_10_47_1 |
| References_xml | – volume: 10 year: 2021 publication-title: Elife – volume: 11 start-page: 1276 year: 2020 publication-title: Front. Immunol. – volume: 7 start-page: 385 year: 2019 publication-title: Diabetes Endocrinol. – volume: 25 start-page: 723 year: 2019 publication-title: Trends Mol. Med. – volume: 33 start-page: 1529 year: 2010 publication-title: Diabetes Care – volume: 11 start-page: 5211 year: 2020 publication-title: Nat. Commun. – volume: 13 start-page: 653 year: 2022 publication-title: Cell Death Dis. – volume: 5 year: 2010 publication-title: PPAR Res. – volume: 321 start-page: 246 year: 2024 publication-title: Immunol. Rev. – volume: 146 year: 2023 publication-title: Microvasc. Res. – volume: 12 start-page: 53 year: 2016 publication-title: Nanomedicine – volume: 1 start-page: 946 year: 2022 publication-title: Nat. Cardiovasc. Res. – volume: 24 year: 2020 publication-title: J. Cell. Mol. Med. – volume: 73 start-page: 924 year: 2021 publication-title: Pharmacol. Rev. – volume: 42 year: 2019 publication-title: Semin. Immunol. – volume: 392 start-page: 393 year: 2023 publication-title: Cell Tissue Res. – volume: 23 start-page: 792 year: 2022 publication-title: Int. J. Mol. Sci. – volume: 11 year: 2020 publication-title: Front. Immunol. – volume: 11 start-page: 1769 year: 2020 publication-title: Nat. Commun. – volume: 21 start-page: 150 year: 2015 publication-title: Nat. Med. – volume: 14 start-page: 2284 year: 2023 publication-title: Aging Dis. – volume: 297 year: 2021 publication-title: J. Biol. Chem. – volume: 187 start-page: 235 year: 2024 publication-title: Cell Death – volume: 12 start-page: 501 year: 2022 publication-title: Adv. Nano Res. – volume: 11 start-page: 1538 year: 2022 publication-title: Cancer Cells – volume: 125 start-page: 590 year: 2019 publication-title: Circ. Res. – volume: 148 start-page: 589 year: 2023 publication-title: Circulation – volume: 61 start-page: 58 year: 2018 publication-title: Diabetologia – volume: 61 start-page: 12 year: 2022 publication-title: Zhonghua Neifenmi Waike Zazhi – volume: 15 start-page: 203 year: 2015 publication-title: Nat. Rev. Immunol. – volume: 43 start-page: 439 year: 2022 publication-title: Annu. Rev. Public Health – volume: 71 start-page: 2551 year: 2022 publication-title: Gut – volume: 9 start-page: 6 year: 2023 publication-title: Cell Discov. – volume: 567 start-page: 525 year: 2019 publication-title: Nature – volume: 109 start-page: 382 year: 2011 publication-title: Circ. Res. – volume: 13 year: 2022 publication-title: Front. Immunol. – volume: 11 start-page: 1 year: 2020 publication-title: Nat. Commun. – volume: 19 start-page: 477 year: 2018 publication-title: BMC Genomics – volume: 12 start-page: 399 year: 2011 publication-title: Genes Immun. – volume: 313 start-page: 120 year: 2023 publication-title: Immunol. Rev. – volume: 183 start-page: 2036 year: 2020 publication-title: Cell – volume: 2022 year: 2022 publication-title: Oxid. Med. Cell. Longevity – volume: 34 start-page: 3223 year: 2018 publication-title: Bioinformatics – volume: 56 start-page: 2325 year: 2023 publication-title: Immunity – volume: 28 start-page: 1 year: 2025 publication-title: Cell Death Differ. – volume: 71 start-page: 2716 year: 2022 publication-title: Diabetes – volume: 1867 year: 2021 publication-title: Biochim. Biophys. Acta, Mol. Basis Dis. – volume: 16 start-page: 278 year: 2020 publication-title: Nat. Chem. Biol. – volume: 5 start-page: 201 year: 2020 publication-title: Signal Transduction Targeted Ther. – volume: 180 start-page: 764 year: 2020 publication-title: Cell – volume: 11 year: 2021 publication-title: Front. Oncol. – volume: 19 start-page: 169 year: 2022 publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 379 start-page: 1214 year: 2012 publication-title: Lancet – volume: 65 start-page: 1695 year: 2016 publication-title: Metabolism – volume: 10 start-page: 1312 year: 2019 publication-title: Front. Immunol. – volume: 402 start-page: 203 year: 2023 publication-title: Lancet – volume: 19 start-page: 1163 year: 2023 publication-title: Int. J. Biol. Sci. – volume: 50 start-page: 941 year: 2019 publication-title: Immunity – volume: 13 year: 2023 publication-title: Sci. Rep. – volume: 19 start-page: 664 year: 2017 publication-title: Diabetes, Obes. Metab. – volume: 185 start-page: 1630 year: 2022 publication-title: Cell – volume: 36 start-page: 122 year: 2016 publication-title: Arterioscler., Thromb., Vasc. Biol. – volume: 10 year: 2021 publication-title: J. Am. Heart Assoc. – volume: 143 year: 2022 publication-title: Vasc. Pharmacol. – volume: 288 start-page: 373 year: 1980 publication-title: Nature – ident: e_1_2_10_61_1 doi: 10.1161/CIRCULATIONAHA.122.063029 – ident: e_1_2_10_26_1 doi: 10.1186/s12864-018-4772-0 – ident: e_1_2_10_17_1 doi: 10.1016/S0140-6736(12)60110-X – ident: e_1_2_10_19_1 doi: 10.1016/j.mvr.2022.104468 – ident: e_1_2_10_21_1 doi: 10.1016/j.vph.2022.106968 – ident: e_1_2_10_38_1 doi: 10.3389/fimmu.2022.988766 – ident: e_1_2_10_57_1 doi: 10.7554/eLife.67481 – ident: e_1_2_10_5_1 doi: 10.1007/s00125-017-4422-0 – ident: e_1_2_10_27_1 doi: 10.1038/s41467-020-14766-3 – ident: e_1_2_10_22_1 doi: 10.14336/AD.2023.0505 – ident: e_1_2_10_42_1 doi: 10.1038/gene.2011.21 – ident: e_1_2_10_60_1 doi: 10.1111/jcmm.15961 – ident: e_1_2_10_65_1 doi: 10.1016/j.molmed.2019.05.010 – volume: 7 start-page: 385 year: 2019 ident: e_1_2_10_4_1 publication-title: Diabetes Endocrinol. – ident: e_1_2_10_41_1 doi: 10.3389/fonc.2021.642144 – ident: e_1_2_10_36_1 doi: 10.1038/s41392-020-00303-7 – ident: e_1_2_10_62_1 doi: 10.1038/nri3818 – ident: e_1_2_10_54_1 doi: 10.1161/ATVBAHA.115.306672 – ident: e_1_2_10_18_1 doi: 10.1038/s41467-020-18957-w – ident: e_1_2_10_43_1 doi: 10.1136/gutjnl-2021-326350 – volume: 10 year: 2021 ident: e_1_2_10_30_1 publication-title: J. Am. Heart Assoc. – ident: e_1_2_10_37_1 doi: 10.1016/j.cell.2020.12.008 – ident: e_1_2_10_53_1 doi: 10.1038/288373a0 – ident: e_1_2_10_49_1 doi: 10.1016/j.bbadis.2021.166170 – ident: e_1_2_10_56_1 doi: 10.1038/s41575-021-00543-0 – ident: e_1_2_10_6_1 doi: 10.1111/dom.12871 – ident: e_1_2_10_16_1 doi: 10.2337/dc09-0354 – ident: e_1_2_10_59_1 doi: 10.1038/nm.3777 – volume: 12 start-page: 501 year: 2022 ident: e_1_2_10_31_1 publication-title: Adv. Nano Res. – ident: e_1_2_10_46_1 doi: 10.3390/cells11091538 – ident: e_1_2_10_51_1 doi: 10.1038/s41467-020-15636-8 – ident: e_1_2_10_28_1 doi: 10.1038/s41421-022-00490-3 – volume: 28 start-page: 1 year: 2025 ident: e_1_2_10_52_1 publication-title: Cell Death Differ. – ident: e_1_2_10_9_1 doi: 10.1016/j.metabol.2016.09.001 – ident: e_1_2_10_50_1 doi: 10.1038/s41419-022-05115-x – volume: 187 start-page: 235 year: 2024 ident: e_1_2_10_11_1 publication-title: Cell Death – ident: e_1_2_10_23_1 doi: 10.7150/ijbs.79915 – volume: 5 year: 2010 ident: e_1_2_10_32_1 publication-title: PPAR Res. – ident: e_1_2_10_58_1 doi: 10.1161/CIRCRESAHA.118.314402 – ident: e_1_2_10_64_1 doi: 10.1038/s41586-019-0979-8 – ident: e_1_2_10_39_1 doi: 10.3389/fimmu.2019.01312 – ident: e_1_2_10_44_1 doi: 10.1038/s41589-019-0462-8 – ident: e_1_2_10_40_1 doi: 10.3390/ijms23020792 – ident: e_1_2_10_48_1 doi: 10.3389/fimmu.2020.598877 – ident: e_1_2_10_25_1 doi: 10.1093/bioinformatics/bty332 – ident: e_1_2_10_47_1 doi: 10.1016/j.smim.2019.101296 – ident: e_1_2_10_63_1 doi: 10.3389/fimmu.2020.01276 – ident: e_1_2_10_7_1 doi: 10.1124/pharmrev.120.000096 – ident: e_1_2_10_20_1 doi: 10.1016/j.cell.2020.01.015 – ident: e_1_2_10_45_1 doi: 10.1111/imr.13147 – ident: e_1_2_10_33_1 doi: 10.1016/j.jbc.2021.101284 – ident: e_1_2_10_35_1 doi: 10.1111/imr.13279 – ident: e_1_2_10_29_1 doi: 10.1161/CIRCRESAHA.111.243444 – ident: e_1_2_10_34_1 doi: 10.1016/j.nano.2015.09.012 – ident: e_1_2_10_13_1 doi: 10.1016/j.immuni.2019.03.007 – ident: e_1_2_10_10_1 doi: 10.1155/2022/7812407 – ident: e_1_2_10_15_1 doi: 10.1038/s41598-023-43221-8 – ident: e_1_2_10_2_1 doi: 10.1146/annurev-publhealth-052620-091107 – ident: e_1_2_10_14_1 doi: 10.1016/j.cell.2022.04.004 – ident: e_1_2_10_1_1 doi: 10.1016/S0140-6736(23)01301-6 – ident: e_1_2_10_24_1 doi: 10.1007/s00441-023-03741-1 – volume: 61 start-page: 12 year: 2022 ident: e_1_2_10_3_1 publication-title: Zhonghua Neifenmi Waike Zazhi – ident: e_1_2_10_8_1 doi: 10.2337/db22-0246 – ident: e_1_2_10_12_1 doi: 10.1016/j.immuni.2023.08.002 – ident: e_1_2_10_55_1 doi: 10.1038/s44161-022-00138-1 |
| SSID | ssj0001537418 |
| Score | 2.334196 |
| Snippet | Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the... Abstract Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction... |
| SourceID | doaj proquest pubmed crossref wiley |
| SourceType | Open Website Aggregation Database Index Database Publisher |
| StartPage | e14530 |
| SubjectTerms | ANGPTL4 Animals Atherosclerosis Cardiovascular disease Cell death Coronary vessels Diabetes Diabetes Mellitus, Experimental - metabolism Diabetic Angiopathies - metabolism Endothelial Cells - metabolism Endothelial Cells - pathology Endothelium Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Fibrosis Gene expression Humans Hypoglycemia Hypoglycemia - complications Hypoglycemia - metabolism Inflammation Macrophages - metabolism Macrophages - pathology Male Mice Mice, Inbred C57BL Molecular biology Mortality Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology PANoptosis proinflammatory polarization Proteins |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYl9NBLadKX26SoUGgLcbOWZT2O6TZLLlkW0pbchJ7twtZe4s3C_or-5c7Y3mULhVyKb9LYSJqR5hs8-oaQd7aCRwqdJyZCztUo5crqIi-TS5Uvoq-i64pNyOlU3dzo2V6pL8wJ6-mB-4U7KyvnXWAuJA2uUikILyCkCxZ54QSPDk9fQD17wVR_P7hEWpYtS-OIndmwRnZucFi8wpTnPS_UkfX_C2H-DVg7jzN5Qh4PUJGe90M8JA9ifUQOh83Y0g8DY_THp-T35WbZ_FhsfPw1txSrcaBAn-wy9_TKwii2Kaf0og5462oBhke_bFp0bKgcuoZX9_vGcbGgs_Nps1w17bw97T-z_AkHEJ1hQDzc4Dyltg70-_XVmE4g9kbZZ-Tb5OLr-DIfKi3knpesyCGKqWRSeO3WAwKIPKnEOU8iyCLJNOLOJ-VHUktQoAA87pnjTgtQMyBGy8rn5KBu6viSUCZU4UtwcioqDtGXQ8QkXIhRQrsuM_J-u_Jm2RNqmJ46mRnUkdnpKCOfUTE7KSTC7hrAPMxgHuY-88jI8VatZtidrSnhnCqRV19m5O2uG_YV_iyxdWzuUIZpAdPQPCMvenPYjYQjrgVol5FPnX3cMxEDCONaIhHdq_8xpdfkEcMixF1G4TE5WN3exRPy0K9X8_b2TbcP_gDQbwpb priority: 102 providerName: Directory of Open Access Journals – databaseName: Wiley-Blackwell Open Access Titles dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBYl7aGXtunTbVpUKLSFmNiSbEnHdJsllywLaUtuRpKlZGFrL-vNwv6K_OXM2F4nC4VSim96oceM5htZ-oaQTyaDT-Y6DiwvY6GSECuj05gHGzKXepd52wabkJOJurjQ03uv-Dt-iOHADTWj3a9RwY1tju5IQ025RrptsEAi4-C0P0xTrjB4AxPTu1OWjCM9C0aYA-865kqILXNjwo52m9ixTC2B_59Q5y6Iba3Q-On_9_8ZedIjUHrcicw-eeCr52S_1_GGfumJqL--IDenm0V9Od84_3tmKAb5wALdHZqZo2cGBrK9yUpPqhIfc81Bnun3TYP2EtecrqHq_byRn8_p9HhSL1Z1M2sOu2YWV7Cv0Sn62f3D0ENqqpL-Oj8b0TGME8u-JD_HJz9Gp3EfwCF2grM0Bucok0Hha14HwMKLoIIQIuSlTIMMibAuKJdILUEucoD5jllhdQ7SA0DUMP6K7FV15d8QynKVOg62U3lYQ51ZBGK5Lb2XkK55RD5vF69YdDwdRcfIzAqc6WKY6Yh8w7UdSiG_dptQLy-LXl0LnllnS2bLoAGgKQVObSLy0iAbYS68jcjBVjKKXumbgsP2x5GuX0bk45AN6or_YEzl62ssw3QOw9AiIq87iRp6IhAuA2KMSCc4fxlIAcDlXCK_3dt_rfCOPGYYx7i9lHhA9lbLa_-ePHLr1axZfmhV6BY_8xuF priority: 102 providerName: Wiley-Blackwell |
| Title | Hypoglycemia Induces Diabetic Macrovascular Endothelial Dysfunction via Endothelial Cell PANoptosis, Macrophage Polarization, and VSMC Fibrosis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fadvs.202414530 https://www.ncbi.nlm.nih.gov/pubmed/40650639 https://www.proquest.com/docview/3257346647 https://www.proquest.com/docview/3229629994 https://doaj.org/article/35bcbd2bdf984688917046da389964eb |
| Volume | 12 |
| WOSCitedRecordID | wos001526665700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: BENPR dateStart: 20141201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: M2O dateStart: 20141201 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: PIMPY dateStart: 20141201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: M2P dateStart: 20141201 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: WIN dateStart: 20140101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2198-3844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001537418 issn: 2198-3844 databaseCode: 24P dateStart: 20140101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdYywMvwPgMjMpISIC0sNRxYucJbaXV9tASMT7KUxQ79qhUktJ0lfpX8C9zl7jdkBA8oEqWGruVrbvz_c45_46QF3kEHxEnvmVx4XMZWF_mSd8PrbKR7hsdGdUUmxCTiZxOk9QduNUurXK7JzYbdVFpPCM_CkG3QuRCF28XP3ysGoVvV10JjT3SRaYy3iHdk-Ek_XB1yhKFSM-yZWsM2FFerJGlGxwXjzD1-Zo3akj7_4Q0fweujecZ3fnfOd8ltx3mpMetkuyTG6a8R_adVdf0laOefn2f_DzdLKqL-Uab77OcYlkPHNBmzcw0HeewjG3uKh2WBV7fmoMG03ebGj0kSpmu4afX-wZmPqfp8aRarKp6Vh-2f7P4BjsZTTGydldBD2leFvTz-XhARxDE49gH5NNo-HFw6ruSDb7mIev7EA5Fwkq8v6sBShhupeWc27gQfStswJW2UgciEaAJMQB7zRRXSQz6AtAzZ-FD0imr0jwmlMWyr0PwltJIDmGcQugVq8IYAc-T0CMvt6LLFi0zR9ZyMLMMhZzthOyRE5TsbhQyajcPquVF5gw0CyOlVcFUYROAZFJCGBvwuMiRfzDmRnnkYCvjzJl5nV0J2CPPd91goPjWJS9NdYljWBLDMhLukUetPu1mwhEgA0b0yJtGwf6xkAygyrlARrsnf5_NU3KLYZ3iJunwgHRWy0vzjNzU69WsXvbIHuMptGIqe85ges1ZBLRj9r5pob-bno3Tr_Dty9nkFwHpIT4 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFL2aNiR4AcZnYICRQIC0sNZxEucBodGtarW1qrQxjacQO_aoVJLSdEX9FfwTfiP35qMbEoKnPaC82U5kO8fXx_b1uQAvEh-fMIhcy4PUFbJlXZlEbdezyvq6bbRvVBlsIhwO5elpNFqDn81dGHKrbGxiaajTXNMe-Y6H2PJICz18P_3mUtQoOl1tQmhUsDgwy--4ZCve9ffw_77kvLt_3Om5dVQBVwuPt11k7H5oJV0x1TjbGWGlFULYIA3bNrQtobSVuhVGIVY2QO6puRIqCrBJyI4SEjpAk78hEOxyHTZG_cHo08Wuju-RHEyjDtniO0m6IFVwnCiFT67Wl2a_MkjAn5jt70S5nOm6t_63ProNN2tOzXarQbAJaya7A5u11SrY61pa-81d-NFbTvOzyVKbr-OEUdgSKlB5BY01GyTYbY1vLtvPUrqeNsERyvaWBTEAQjFb4KuX8zpmMmGj3WE-nefFuNiuPjP9gpaajWjnoL7qus2SLGUnR4MO647VjMreg49X0jH3YT3LM_MQGA9kW3vIBqSRApepiqhloFJjQkyPPAdeNVCJp5XySFxpTPOYQBWvQOXAB0LSqhQphpcJ-ewsrg1Q7PlKq5Sr1EZIOaXEZXpLBGlC-oqBMMqBrQZTcW3GivgCUA48X2WjAaJTpSQz-TmV4VGAzYiEAw8q_K5qImgBgBzYgbcloP_RkBip2FFIin2P_l6bZ3C9dzw4jA_7w4PHcINTTObSwXIL1uezc_MErunFfFzMntYDlMHnq8b7L0Ssc-w |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFL2aBkK8AOMzMMBIIEBaaOs4sfOA0OhWbRorlQZobyF27FGpJKXpivor-D_8Ou7NRzckBE97QHlLnMh2ju89tq_PBXiahnjJKPYdjzJfqK7zVRr3_MBpF5qeNaHVVbIJORyq4-N4tAY_27MwFFbZ2sTKUGeFoTXyToDYCkgLXXZcExYx2hm8mX7zKYMU7bS26TRqiBzY5XecvpWv93fwXz_jfLD7ob_nNxkGfCMC3vORvYfSKTpuatDzWeGUE0K4KJM9J11XaOOU6cpYYsUj5KGGa6HjCJuHTCkl0QM0_5ekQKdMYYP8_dn6ThiQMEyrE9nlnTRbkD44ukwRUtD1OT9YpQv4E8f9nTJXPm9w_X_urRtwrWHabLseGhuwZvObsNHYspK9aAS3X96CH3vLaXEyWRr7dZwySmZCBepYobFhhyl2YRuxy3bzjA6tTXDcsp1lSbyAsM0W-Or5Z307mbDR9rCYzotyXG7Vn5l-QfvNRrSe0ByA3WJpnrFPR4d9NhjrGZW9DR8vpGPuwHpe5PYeMB6pngmQIyirBE5eNRHOSGfWSrwfBx48b2GTTGs9kqRWnuYJASxZAcyDt4SqVSnSEa9uFLOTpDFLSRBqozOuMxcjEVUKJ-9dEWUpqS5GwmoPNlt8JY1xK5MzcHnwZPUYzRLtNaW5LU6pDI8jbEYsPLhbY3lVE0HTAmTGHryqwP2PhiRI0I4k6fjd_3ttHsMVBHnybn948ACuckrUXEVdbsL6fHZqH8Jls5iPy9mjaqQy-HzRYP8FdGh7Jg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoglycemia+Induces+Diabetic+Macrovascular+Endothelial+Dysfunction+via+Endothelial+Cell+PANoptosis%2C+Macrophage+Polarization%2C+and+VSMC+Fibrosis&rft.jtitle=Advanced+science&rft.au=Zuo%2C+Deyu&rft.au=Peng%2C+Yuce&rft.au=Zhao%2C+Guozhi&rft.au=Cheng%2C+Zhesheng&rft.date=2025-10-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2198-3844&rft.volume=12&rft.issue=37&rft_id=info:doi/10.1002%2Fadvs.202414530&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2198-3844&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2198-3844&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2198-3844&client=summon |